Industry chatter suggests a2 Milk is preparing to deploy over A$350 million toward a New Zealand acquisition, a move that would reinforce its manufacturing footprint and safeguard access to the Chinese infant formula market. The company has not commented publicly on the potential deal.
No Confirmation But Strategic Indicators Emerge
The Australian has reported that a2 Milk is targeting a manufacturing asset acquisition that could include canning and blending operations tied to its Chinese infant formula strategy. The company issued a brief statement: “a spokesman for a2 Milk reiterated the company’s policy of not commenting on market speculation.”
CEO David Bortolussi spoke of the company’s goals in February, stating: “As we look ahead, obtaining access to additional China-label infant milk formula registrations to support future growth and developing our own nutritional manufacturing capability remain critical to the company’s supply chain transformation strategy.” He further noted, “While we are not sharing any new information with you today, we continue to progress opportunities with the intent of making meaningful progress this year.”
Capital Allocation Signals Acquisition Readiness
a2 Milk is well-positioned to make a sizeable acquisition, with over $1 billion in cash on hand as of its first-half financial results. Broker Jarden has called such a move “on target” for the company, estimating that it could have $400 million available for transactions in the 2026 financial year.
Jarden also highlighted the current market conditions, noting that the New Zealand dairy sector is “ready for consolidation given its oversupply status,” although it warned that any deal could be “complicated by various factors – both technical fit and registration status.”
The Potential Target is Yashili NZ
One possible target is Yashili New Zealand, a facility located in Pōkeno near Synlait Milk—currently a2 Milk’s key manufacturing partner. Jarden noted the proximity and also pointed to a2 Milk’s supply chain executive Chopin Zhang’s previous experience with Yashili, suggesting a potential fit between the two companies.
Yashili NZ, owned by China Mengniu Dairy, reported a net equity of $271 million and a net loss after tax of $26 million for the year ended December 2023.
Its plant includes infrastructure for milk input processing, base ingredient production, and canned formula manufacturing. Its property, plant and equipment is valued at $204 million, while $8 million has been invested in development costs related to China’s infant milk formula registration standards.
Stability Amidst Uncertainty
Investors appear to be cautiously optimistic despite the mounting speculation. Shares in a2 Milk last traded at $8.97, up one cent and the stock is up 13% so far this year.
While no official announcements have been made, a2 Milk’s movements and silence suggest something may be underway. The company has made clear that securing regulatory-ready manufacturing capacity is critical to its strategy.